Abstract
Airway diseases are a major cause of morbidity and mortality in the UK, accounting for a large number of visits of patients to the primary care physicians. The variety of diseases include pulmonary inflammation and infection, as well as lung cancer, the most common cancer in men. The lung presents a huge exposed surface to the air allowing the entrance of a variety of particulate matter onto the epithelial surfaces. These particulate substances encompass a range of pathogens (e.g. bacteria, viruses, fungi, etc.) as well as particulate matter, which may promote an antigenic response (e.g. pollens, house dust, mite, etc.), particles that are potentially carcinogenic as in cigarette smoke, or fibres such as asbestos producing other responses in the pleura.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
O’Doherty, M.J. and Miller, R.F. (1993) Aerosols for therapy and diagnosis. Eur. J. Nucl. Med., 20, 1201–13.
Staub, N.C., Hyde, R.W. and Crandall, E. (1990) Workshop on techniques to evaluate lung alveolar-micro vascular injury. Am. Rev. Respir. Dis., 141, 1071–7.
Taplin, G.V., Chopra, S.K. and Uszler, J.M. (1978) Imaging experimental pulmonary ischaemic lesions after inhalation of a diffusible radioaerosol. Recent experience and further developments. J. Nucl. Med., 19, 567–8.
Jones, J.G., Minty, B.D., Lawler, P., Hulands, G., Crawley, J.C.W. and Veall, N. (1980) Increased epithelial permeability in cigarette smokers. Lancet, i, 66–8.
Barrowcliffe, M.P. and Jones, J.G. (1989) Pulmonary clearance of 99mTc-DTPA in the diagnosis and evolution of increased permeability pulmonary oedema. Anaesth. Intens. Care, 17, 422–32.
Jefferies, A.L., Coates, G. and O’Brodovich, H. (1984) Pulmonary epithelial permeability in Hyaline-Membrane disease. N. Engl. J. Med., 311, 1075–80.
O’Doherty, M.J., Page, C.J., Bradbeer, C.S. et al. (1987) Alveolar permeability in HIV patients with Pneumocystis carinii pneumonia. Genitourin. Med., 63, 268–70.
O’Doherty, M.J., Page, C.J., Bradbeer, C.S. et al. (1989) The place of lung 99mTc DTPA aerosol transfer in the investigation of lung infections in HIV positive patients. Resp. Med., 83, 395–401.
Mason, G.R., Effros, R.M., Uszler, J.M. et al (1985) Small solute clearance from the lungs of patients with cardiogenic and noncardiogenic pulmonary edema. Chest, 88, 327–34.
Oberdorster, G., Utell, M.J., Weber, D.A., Ivanovich, M., Hyde, R.W. and Morrow, P.E. (1984) Lung clearance of inhaled 99m-Tc DTPA in the dog. J. Appl. Physiol, 57, 589–95.
Langford, J.A., Lewis, C.A., Geliert, A.R., Tolfree, S.E.J., and Rudd, R.M. (1986) Pulmonary epithelial permeability: vascular background effects on whole lung and regional half-time values. Nucl Med. Commun., 7(3), 183–90.
Kohn, H., Kohn, B., Klech, H., Pohl, W. and Mostbeck, A. (1990) Urine excretion of inhaled technetium-99m-DTPA: an alternative method to assess lung epithelial transport. J. Nucl Med., 31(4), 4419.
Groth, S. and Pedersen, M. (1989) Pulmonary permeability in primary ciliary dyskinesia. Eur. Respir. J., 2, 64–70.
Barrowcliffe, M. P., Otto, C and Jones, J.G. (1988) Pulmonary clearance of 99mTc-DTPA: influence of background activity. J. Appl. Physiol, 64(3), 1045–9.
O’Doherty, M.J., Page, CT., Croft, D.N. and Bateman, N.T. (1985) Lung 99WTc DTPA transfer: a method for background correction. Nucl. Med. Commun., 6, 209–15.
O’Doherty, M.J., Page, C.J., Croft, D.N. and Bateman, N.T. (1985) Regional lung ‘leakiness’ in smokers and nonsmokers. Nucl. Med. Commun., 6, 353–7.
Basran, G.S., Byrne, A.J. and Hardy, J.G. (1985) A noninvasive technique for monitoring lung vascular permeability in man. Nucl Med. Commun., 3, 3–10.
Braude, S., Apperley, J., Krausz, T., Goldman, J.M. and Royston, D. (1985) Adult Respiratory Distress Syndrome after allogeneic bone marrow transplantation: evidence for a neutrophil independent mechanism. Lancet, i, 1239–42.
Kaplan, J.D., Calandrino, F.S. and Schuster, D.P. (1991) A positron emission tomographic comparison of pulmonary vascular permeability during the adult respiratory distress syndrome and pneumonia. Am. Rev. Respir. Dis., 143, 150–4.
Velazquez, M., Weibel, E.R., Kuhn, C. et al. (1991) PET evaluation of pulmonary vascular permeability: a structure-function correlation. J. Appl. Physiol. 70, 2206–16.
Mintun, M.A., Dennis, D.R., Welch, M.J., Mathias, C.J. and Schuster, D.P. (1987) Measurements of pulmonary vascular permeability with PET and gallium-68-transferrin. J. Nucl. Med., 28, 1704–16.
Mintun, M.A., Warfel, T.E. and Schuster, D.P. (1990) Evaluating pulmonary vascular permeability with radiolabeled proteins: an error analysis. J. Appl Physiol, 68, 1696–706.
Bekerman, C., Hoffer, P.B., Bitran, J.D. and Gupta, R.G. (1980) Gallium-67 citrate imaging studies of the lung. Semin. Nucl. Med., 10, 286–301.
Chinet, T., Jaubert, F., Dusser, D., Danei, C., Chretien, J. and Huchon, G.J. (1990) Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis. Thorax, 45, 675–8.
Dusser, D.J., Collignon, M.A., Stanislas-Leguern, G., Barritault, L.G., Chretien, J. and Huchon, G.J. (1986) Respiratory clearance of 99mTc DTPA and pulmonary involvement in sarcoidosis. Am. Rev. Respir. Dis., 134, 493–7.
Watanabe, N., Inoue, T., Oriuchi, H., Suzuki, H., Hirano, T. and Endo, K. (1995) Increased pulmonary clearance of aerosolised 99mTc-DTPA in patients with a subset of stage I sarcoidosis. Nucl Med. Commun., 16, 464–7.
Line, B.R., Hunninghake, G.W., Keogh, B.A. et al (1981) Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies and bronchoalveolar lavage. Am. Rev. Respir. Dis., 123, 440–6.
Sulavik, S.B., Spencer, R.P., Palestro, C.J. et al (1993) Specificity and sensitivity of distinctive chest radiographic and / or 67Ga images in the noninvasive diagnosis of sarcoidosis. Chest, 103, 403–9.
Sulavik, S.B., Spencer, R.P., Weed, D.A., Shapiro, H.R., Shiue, S. and Castriotta, R.J. (1990) Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J. Nucl. Med., 31, 1909–14.
Baughman, R.P., Fernandez, M. and Bosken, C. (1984) Comparison of gallium-67 scanning, bronchoalveolar lavage and serum angiotensin-converting enzyme levels in pulmonary sarcoidosis: predicting response to therapy. Am. Rev. Respir. Dis., 129, 676–81.
Lawrence, E.C., Teague, R.B. and Gottlieb, M.S. (1983) Serial changes in markers of disease activity with corticosteroid treatment in sarcoidosis. Am. J. Med., 74, 747–56.
Alberts, C. and Van der Schoot, J.B. (1988) Standardized quantitative 67Ga scintigraphy in pulmonary sarcoidosis. Sarcoidosis, 5, 111–18.
Vanhagen, P.M., Krenning, E.P., Reubi, J.C. et al (1994) Somatostatin analogue scintigraphy in granulomatous disease. Eur. J. Nucl. Med., 21, 497–502.
Diot, R., Lemarie, E., Baulie, J.L. et al. (1992) Scintigraphy with J001 macrophage targeting glycolipeptide. A new approach for sarcoidosis imaging. Chest, 102, 670–6.
Kubota, R., Yamada, S., Kubota, K., Ishiwata, K., Tamahashi, N. and Ido, T. (1992) Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulocytes studied by microautoradiography. J. Nucl Med., 33, 1972–80.
Lewis, P.J. and Salama, A. (1994) Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J. Nucl Med., 35, 1647–9.
Valind, S.O., Rhodes, C.G., Paltin, C., Suzuki, T. and Hughes, J.M.B. (1984) Measurements of pulmonary glucose metabolism in patients with cryptogenic fibrosing alveolitis and pulmonary sarcoidosis. Am. Rev. Respir. Dis., 129, A53.
Brudin, L.H., Valind, S.O., Rhodes, C.G. et al (1994) Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur.]. Nucl. Med., 21, 297–305.
Further Reading
Clarke, D., Mitchell, A.W.M., Dick, R. and James, G.D. (1994) The radiology of sarcoidosis. Sarcoidosis, 11, 90–9.
O’Doherty, M.J. and Peters, A.M. (1997) Pulmonary technetium-99m diethylene triamine pentaacetic acid aerosol clearance as an index of lung injury. Eur. J. Nucl. Med., 24, 81–7.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
O’Doherty, M.J. (1998). Other pulmonary applications. In: Maisey, M.N., Britton, K.E., Collier, B.D. (eds) Clinical Nuclear Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3356-0_19
Download citation
DOI: https://doi.org/10.1007/978-1-4899-3356-0_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-75180-6
Online ISBN: 978-1-4899-3356-0
eBook Packages: Springer Book Archive